feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / AIIMS Delhi Trial: Supernova Stent Safe for Strokes

AIIMS Delhi Trial: Supernova Stent Safe for Strokes

14 Dec, 2025

•

Summary

  • Supernova stent is safe and effective for stroke patients.
  • Trial showed high restoration of blood flow, low brain bleed.
  • Device offers hope to millions of Indians suffering strokes annually.

The Supernova Stent, a new advanced brain treatment device, has been confirmed as safe and effective for stroke patients by experts at AIIMS Delhi. AIIMS served as the national coordinating center for the GRASSROOT trial, a groundbreaking clinical study.

Preliminary results from the trial, published in the Journal of Neurointerventional Surgery, indicate excellent safety and efficacy. The Supernova stent retriever achieved high rates of successful blood flow restoration, with a low incidence of brain bleeds (3.1%), mortality (9.4%), and a 50% functional independence rate at 90 days.

Developed by Gravity Medical Technology, the Supernova stent is designed for India's diverse population and has already received approval for routine use. The trial's success is a milestone for the Make-in-India initiative, positioning India as a leader in advanced stroke care and offering affordable treatment options to millions.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The Supernova Stent is a new brain treatment device shown to be safe and effective in the GRASSROOT trial led by AIIMS Delhi, achieving high blood flow restoration.
The Supernova Stent offers a safe, effective, and affordable treatment option for the 1.7 million Indians who suffer strokes annually, potentially improving functional independence.
The GRASSROOT trial is the first prospective multicentre thrombectomy trial in India that evaluated the safety and efficacy of the Supernova stent retriever.

Read more news on

Healthside-arrow
trending

Silver hits all-time high

trending

Seven Dials killer twist

trending

Mammootty cameo in wrestling film

trending

Praveen Kumar heads BSF

trending

Nithin Kamath questions market closure

trending

BTS new album Arirang

trending

iPhone 15 Pro Max Review

trending

Cancelo returns to Barcelona

trending

UP Warriorz beat Mumbai Indians

You may also like

India Tackles Dementia: A Data-Driven Approach

20 Dec, 2025 • 113 reads

article image

AI Meets Ancient Wisdom: WHO Conference Begins

18 Dec, 2025 • 138 reads

article image

Heart Intervention Course Boosts Patient Safety

16 Dec, 2025 • 93 reads

article image

India's Snakebite Crisis: New ICMR Project Targets Zero Deaths

13 Dec, 2025 • 115 reads

article image

Swaraj Kaushal, 73, Passes Away After Chest Pain

4 Dec, 2025 • 199 reads

article image